Hyperlyte - 0264-1943-20 - (Multi Electrolyte Concentrate)

Alphabetical Index


Drug Information of Hyperlyte

Product NDC: 0264-1943
Proprietary Name: Hyperlyte
Non Proprietary Name: Multi Electrolyte Concentrate
Active Ingredient(s): .37; .51; 1.96; .68; 1.17    g/20mL; g/20mL; g/20mL; g/20mL; g/20mL & nbsp;   Multi Electrolyte Concentrate
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION, CONCENTRATE
Coding System: National Drug Codes(NDC)

Labeler Information of Hyperlyte

Product NDC: 0264-1943
Labeler Name: B. Braun Medical Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number:
Marketing Category: UNAPPROVED DRUG OTHER
Start Marketing Date: 20120412

Package Information of Hyperlyte

Package NDC: 0264-1943-20
Package Description: 12 CONTAINER in 1 CASE (0264-1943-20) > 250 mL in 1 CONTAINER

NDC Information of Hyperlyte

NDC Code 0264-1943-20
Proprietary Name Hyperlyte
Package Description 12 CONTAINER in 1 CASE (0264-1943-20) > 250 mL in 1 CONTAINER
Product NDC 0264-1943
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Multi Electrolyte Concentrate
Dosage Form Name INJECTION, SOLUTION, CONCENTRATE
Route Name INTRAVENOUS
Start Marketing Date 20120412
Marketing Category Name UNAPPROVED DRUG OTHER
Labeler Name B. Braun Medical Inc.
Substance Name CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM ACETATE; SODIUM ACETATE; SODIUM CHLORIDE
Strength Number .37; .51; 1.96; .68; 1.17
Strength Unit g/20mL; g/20mL; g/20mL; g/20mL; g/20mL
Pharmaceutical Classes Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient]

Complete Information of Hyperlyte


General Information